A study found that COVID-19 vaccinations play a key role in the drop in Long COVID cases, declining with each variant, including pre-Delta, Delta and Omicron eras.
[ Read More ]
A new study published in Nature Immunology shows mucosal vaccine boosters are expected to enhance protection against SARS-CoV-2 infection. The study reveals that the delivery device — through either intranasal sprayers or nebulizers — also influences the mucosal immunity and protection efficacy in nonhuman primates.
[ Read More ]
Researchers at Cleveland Clinic's Lerner Research Institute have reported that their universal flu vaccine candidate, tested on animal models, elicited a strong immune response and provided protection against severe infection after viral exposure. The researchers hope to launch human clinical trials within one to three years.
[ Read More ]
Advancing Your Medical Knowledge Is Easier Than Ever
Overhauled and updated, our
BioSupply Trends Quarterly website refresh makes staying up to date on medical news and insights accessible and easy. On the new BSTQ, you'll find:
Breaking industry news
Updates on clinical research, FDA approvals, healthcare regulations and legislation
The latest information on disease states, diagnostic tools and therapeutics
Facility administration and reimbursement resources
Current and past BSTQ issue archives
And so much more!
The same quality content you trust, redesigned with you in mind:
www.bstquarterly.com
The U.S. Food and Drug Administration has granted emergency use authorization for an updated version of Novavax’s COVID-19 vaccine, which targets the JN.1 strain of the virus, for individuals 12 years of age and older.
[ Read More ]
Updated mRNA COVID-19 vaccines (2024-2025 formula) to include a monovalent (single) component that corresponds to the Omicron variant KP.2 strain of SARS-CoV-2 have been approved and granted emergency use authorization by the U.S. Food and Drug Administration. The mRNA COVID-19 vaccines have been updated with this formula to more closely target currently circulating variants and provide better protection against serious consequences of COVID-19, including hospitalization and death.
[ Read More ]
The U.S. Food and Drug Administration has approved the first needle-free alternative to the EpiPen. Neffy is a single-use epinephrine nasal spray for the emergency treatment of allergic reactions, including anaphylaxis, in adult and pediatric patients who weigh at least 30 kilograms (about 66 pounds).
[ Read More ]
IVIG & Albumin Supply Index
IVIG and Albumin Supply Index represents FFF's aggregate inventory of both products for all our customers who have established product allocations with us (not individual or group allocations).
HYDROMORPHONE HYDROCHLORIDE injection is an opioid agonist indicated for the management of pain severe enough to require an opioid analgesic and for which the alternate treatments are inadequate. It is supplied in single dose colorless viles with each mL of sterile, aqueous solution containing 1 mg, 2 mg or 4 mg of hydromorphone hydrochloride with 0.2% sodium citrate and 0.2% citrate acid solution.
[ Learn More ]
JYNNEOS is a vaccine indicated for the prevention of smallpox and monkeypox disease in adults 18 years of age and older determined to be at high risk for smallpox or monkeypox infection. It is supplied in a package of 10 single-dose vials.
[ Learn More ]
RABAVERT is indicated for preexposure vaccination, in both primary series and booster dose, and for postexposure prophylaxis against rabies in all age groups. It is supplied as a single-dose kit containing one vial of freeze-dried vaccine containing a single dose, one disposable prefilled syringe of sterile diluent for reconstitution (1 mL), one small needle for injection (25 guage, 1 inch), and one long needle for reconstitution (21 gauge, 1½ inches).
[ Learn More ]
VIVOTIF (typhoid vaccine live oral Ty21A) is indicated for immunization in adults and children greater than 6 years of age against disease caused by Salmonella typhi. It is supplied in a single foil blister containing four doses of vaccine in a single package.
[ Learn More ]
VIBATIV is a lypoglycopeptide antibacterial drug indicated for the treatment of the following infections in adult patients caused by designated susceptible bacteria: complicated skin and skin structure infections (cSSSI); and hospital-acquired and ventilator-associated bacterial pneumonia (HABP/VABP) caused by susceptible isolates Staphylococcus aureaus. It is supplied in individual cartons of 750 mg single-dose vials; cartons of 12 individually packaged 750 mg single-dose vials; and cartons of four individually packaged 750 mg single-dose vials.
[ Learn More ]
MRESVIA is a vaccine indicated for active immunization for the prevention of lower respiratory tract disease (LRTD) caused by respiratory syncytial virus (RSV) in individuals 60 years of age and older. It is supplied as a single-dose prefilled plastic syringe in a blister pack containing one dose of 0.5 mL, and in a carton of 10 single-dose prefilled plastic syringes, each syringe containing one dose of 0.5 mL. Each carton contains 5 blisters, and each blister contains two syringes.
[ Learn More ]
REGADENOSON injection is a pharmacologic stress agent indicated for radionuclide myocardial perfusion imaging in patients unable to undergo adequate exercise stress. It is supplied as a sterile, preservative-free solution containing 0.08 mg/mL regadenoson in single-dose 5 mL prefilled syringes with a luer-lock fitting.
[ Learn More ]
IXCHIQ is a vaccine indicated for the prevention of disease caused by chikungunya virus (CHIKV) in individuals 18 years of age and older who are at increased risk of exposure to CHIKV. It is supplied in a carton containing one single-dose vial of lyophilized antigen component, live, and one prefilled ungraduated syringe of sterile water diluent component (packaged without needles).
[ Learn More ]
HIBERIX is a vaccine indicated for active immunization for the prevention of invasive disease caused by Haemophilus influenzae type b in children aged 6 weeks through 4 years (prior to fifth birthday). HIBERIX vial and vial presentation is supplied in a carton packaged without syringes or needles containing 10 single-dose vials of lyophilized antigen component and 10 single-dose vials of sterile saline diluent. HIBERIX vial and prefilled syringe presentation is supplied in a carton containing 10 single-dose vials of lyophilized antigen component and 10 single-dose prefilled ungraduated TIP-LOK syringes of sterile saline diluent packaged without needles.
[ Learn More ]
ZEMAIRA is an alpha1-proteinase inhibitor (A
1-PI; human) indicated for chronic augmentation and maintenance therapy in adults with A
1-PI deficiency and clinical evidence of emphysema. It is supplied in single-dose vials containing 1,000 mg, 4,000 mg or 5,000 mg functionally active A
1-PI.
[ Learn More ]
COMIRNATY (mRNA) is a vaccine indicated for active immunization to prevent coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in individuals 12 years of age and older. It is supplied in cartons of 10 single-dose glass prefilled syringes, single-dose plastic prefilled syringes and single-dose vials.
[ Learn More ]
CARBOPLATIN injection is indicated for the initial treatment of advanced ovarian carcinoma in established combination with other approved chemotherapeutic agents, and for the palliative treatment of patients with ovarian carcinoma recurrent after prior chemotherapy, including patients who have been previously treated with cisplatin. It is supplied in 5 mL fill in 10 mL, 15 mL fill in 20 mL, 45 mL fill in 50 mL and 60 mL fill in 100 mL multiple-dose vials.
[ Learn More ]
The Novavax COVID-19 Vaccine (Adjuvanted/Protein Subunit) is a vaccine indicated for active immunization to prevent coronavirus disease (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in individuals 12 years of age and older. It is supplied in boxes of 10 doses of 0.5 mL Pre-filled Syringes.
[ Learn More ]
AREXVY is a vaccine indicated for active immunization for the prevention of lower respiratory tract disease caused by respiratory syncytial virus in individuals 60 years of age and older. It is supplied as two components: a single-dose vial of lyophilized antigen component (powder) and a single-dose vial of adjuvant suspension component (liquid) (packaged without syringes or needles) in cartons of 10 vials.
[ Learn More ]
ABRYSVO is a vaccine indicated for active immunization for the prevention of lower respiration tract disease caused by respiratory syncytial virus in individuals 60 years of age and older. It is supplied in a kit that includes a vial of lyophilized antigen component, a prefilled syringe containing sterile water diluent component and a vial adapter in cartons of one, five and 10 kits.
[ Learn More ]
INDOCIN is a nonsteroidal anti-inflammatory drug indicated for moderate to severe rheumatoid arthritis, including acute flares of chronic disease; moderate to severe ankylosing spondylitis; moderate to severe osteoarthritis; acute painful shoulder (bursitis and/or tendinitis); and acute gouty arthritis. The 50 mg suppositories (indomethacin suppositories USP) are white, opaque and rectal supplied in boxes of 30.
[ Learn More ]
BioSupply Trends Quarterly magazine is the definitive source for industry trends, news and information for the biopharmaceuticals marketplace.
[ BST Quarterly Magazine ]
IG Living is the only magazine for the immune globulin (IG) community for patients who suffer from chronic illness and their caregivers.
[ IG Living Magazine ]
Healthcare Resources
Posters, Charts & Brochures
FFF Enterprises offers complimentary seasonal vaccine resources to help you with your healthcare practice.
[ Order Free Vaccine Resources ]
